
Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
Martin Wisher, PHD, is senior director, global head of regulatory affairs for BioReliance at MilliporeSigma.
Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
Published: September 1st 2018 | Updated: